Julie Krop
Direttore/Membro del Consiglio presso AQUESTIVE THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Julie Krop
Società | Posizione | Inizio | Fine |
---|---|---|---|
AQUESTIVE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 10/02/2021 | - |
Independent Dir/Board Member | - | - | |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 01/10/2021 | - |
Storia della carriera di Julie Krop
Precedenti posizioni note di Julie Krop
Società | Posizione | Inizio | Fine |
---|---|---|---|
PURETECH HEALTH PLC | Direttore Tecnico/Scientifico/R&S | 13/08/2021 | 31/03/2024 |
FREELINE THERAPEUTICS HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | 01/04/2020 | 01/08/2021 |
AMAG PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2015 | 01/01/2021 |
Consigliere Generale | 01/06/2015 | - | |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/01/2001 | 01/05/2015 |
STRYKER CORPORATION | Corporate Officer/Principal | 01/01/2006 | 01/01/2012 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Direttore Tecnico/Scientifico/R&S | 01/01/2003 | 01/01/2006 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | 01/01/2003 |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Julie Krop
Brown University | Undergraduate Degree |
The Warren Alpert Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Regno Unito | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 5 |
Corporate Officer/Principal | 4 |
General Counsel | 1 |
Settori
Health Technology | 10 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
STRYKER CORPORATION | Health Technology |
PFIZER, INC. | Health Technology |
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
PURETECH HEALTH PLC | Health Technology |
Aziende private | 5 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Freeline Therapeutics Holdings Plc
Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
- Borsa valori
- Insiders
- Julie Krop
- Esperienza